The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

Historical epidemiological analysis has demonstrated an association between urbanisation and growing cancer burden across the ...

Q32 Bio has stopped a Phase II trial of its former lead renal disease candidate as it focuses on its alopecia areata ...

BMS has reported that the Phase II TRANSCEND FL trial assessing Breyanzi, met its primary endpoint in the marginal zone ...

Nerandomilast is posed to be Boehringer Ingelheim’s successor to its blockbuster Ofev (nintedanib)in IPF and PPF.

Being realistic, responsive and transparent is key in engaging unresponsive and underperforming clinical trial sites; that ...